Icell Kealex Therapeutics Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Icell Kealex Therapeutics General Information
Description
Developer of T-cell engager-armed oncolytic virus intended for the treatment of solid tumors. The company is combining vaccinia virus (VV) with T-cell-based immunotherapy loading it with T-cell engagers, creating T-cell engager-armed oncolytic vaccinia virus, helping healthcare service providers to treat their patients easily.
Contact Information
Website
www.icellkealex.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
- 2450 Holcombe Boulevard
- Houston, TX 77021
- United States
+1 (346) 000-0000
Icell Kealex Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 02-Mar-2016 | Completed | Generating Revenue |
Icell Kealex Therapeutics Patents
Icell Kealex Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019367965-A1 | Mutant vaccinia viruses and use thereof | Pending | 22-Oct-2018 | 0000000000 | |
| CA-3117378-A1 | Mutant vaccinia viruses and use thereof | Pending | 22-Oct-2018 | 0000000000 | |
| EP-3870217-A1 | Mutant vaccinia viruses and use thereof | Pending | 22-Oct-2018 | 0000000000 | |
| EP-3870217-A4 | Mutant vaccinia viruses and use thereof | Pending | 22-Oct-2018 | 0000000000 | 0 |
| US-20210388388-A1 | Mutant vaccinia viruses and use thereof | Pending | 22-Oct-2018 | C07K14/005 |
Icell Kealex Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Shautong Song | Founder & Co-Chief Executive Officer | ||
| Xiao-Tong Song | Co-Founder |
Icell Kealex Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | 000 0000 | 000000 0 |